AVDL

Avadel Pharmaceuticals

75 hedge funds and large institutions have $126M invested in Avadel Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding:

less ownership

Funds ownership:

33% less capital invested

Capital invested by funds: $189M → $126M (-$62.7M)

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$678K
Puts
$594K
Net Calls
Net Calls Change

Top Buyers

1 +$1.64M
2 +$991K
3 +$833K
4
Citadel Advisors
Citadel Advisors
Florida
+$793K
5
BC
Broadfin Capital
New York
+$613K

Top Sellers

1 -$13.4M
2 -$9.45M
3 -$6.54M
4
Morgan Stanley
Morgan Stanley
New York
-$3.98M
5
GTC
Ghost Tree Capital
New York
-$2.45M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$357K
27
$315K
28
$307K
29
$258K
30
$230K
31
$227K
32
$226K
33
$213K
34
$178K
35
$173K
36
$155K
37
$144K
38
$143K
39
$129K
40
$123K
41
$117K
42
$108K
43
$108K
44
$107K
45
$95K
46
$95K
47
$92K
48
$77K
49
$75K
50
$72K